Pre-Open Stock Movers 07/24: (ABUS) (SKX) (AMD) Higher; (EHTH) (INTC) (TSLA) Lower (more...)

July 24, 2020 9:30 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Pre-Open Stock Movers:

Arbutus Biopharma Corporation (NASDAQ: ABUS) 28.6% HIGHER; adds to Thursday's 120% surge which was related to a patent win against Moderna.

eHealth (NASDAQ: EHTH) 23.7% LOWER; reported Q2 EPS of $0.07, $0.21 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $88.8 million versus the consensus estimate of $80.78 million. eHealth sees FY2020 EPS of $3.83-$4.32, versus the consensus of $3.82. eHealth sees FY2020 revenue of $630-670 million, versus the consensus of $639.48 million.

Clearfield, Inc. (NASDAQ: CLFD) 21.5% HIGHER; Record Revenue Driven by 48% Increase in Multiple System Operator Revenue, 22% Increase in Community Broadband Revenue and 19% Increase in Tier 1 Revenue over Prior Year Quarter, Offset by Lower International Sales.

ChannelAdvisor Corporation (NYSE: ECOM) 17.8% HIGHER; announced that it has acquired BlueBoard, a leading e-commerce analytics company. Headquartered in Paris, France, BlueBoard helps leading global brands such as L'Oreal, Clarins, and Logitech gain a competitive advantage on their e-commerce channels with actionable insights into how their products are performing across thousands of retailer websites and marketplaces. Issues preliminary Q2 results.

SciPlay Corporation (NASDAQ: SCPL) 14.6% HIGHER; reported Q2 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $165.5 million versus the consensus estimate of $137.2 million.

Intel (NASDAQ: INTC) 13.9% LOWER; reported Q2 EPS of $1.23, $0.12 better than the analyst estimate of $1.11. Revenue for the quarter came in at $19.7 billion versus the consensus estimate of $18.55 billion. Intel sees FY2020 EPS of $4.85, versus the consensus of $4.81. Intel sees FY2020 revenue of $75 billion, versus the consensus of $73.86 billion. Intel sees Q3 EPS of $1.10, versus the consensus of $1.14. Intel sees Q3 revenue of $18.2 billion, versus the consensus of $17.9 billion. Intel's next generations 7nm technology is a month behind schedule.

Bj's Restaurants, Inc. (NASDAQ: BJRI) 11.8% HIGHER; reported Q2 EPS of ($1.38), $0.57 better than the analyst estimate of ($1.95). Revenue for the quarter came in at $128 million versus the consensus estimate of $128.64 million.

The Menarini Group and Radius Health, Inc. (Nasdaq: RDUS) 10.2% HIGHER; announced today that the companies have entered into an exclusive global license agreement for development and commercialization of elacestrant.

Skechers USA (NYSE: SKX) 9.4% HIGHER; reported Q2 EPS of ($0.44), $0.22 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $729.5 million versus the consensus estimate of $659.68 million.

Mattel (NASDAQ: MAT) 7.7% HIGHER; reported Q2 EPS of ($0.26), $0.08 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $732 million versus the consensus estimate of $678.52 million.

Advanced Micro Devices, Inc. (NASDAQ: AMD) 7.3% HIGHER; Gains tied to news Intel's next generations 7nm technology is a month behind schedule.

Boston Beer Co. (NYSE: SAM) 6.5% HIGHER; reported Q2 EPS of $4.88, $2.46 better than the analyst estimate of $2.42. Revenue for the quarter came in at $452.1 million versus the consensus estimate of $429.58 million. Boston Beer Co. sees FY2020 EPS of $11.70-$12.70, versus the consensus of $9.54.

NuCana (NASDAQ: NCNA) 5.8% HIGHER; Oppenheimer initiates coverage on with an Outperform rating and a price target of $20.00.

Tesla, Inc. (NASDAQ: TSLA) 5.7% LOWER; continues post-earnings consolidation

Edwards Lifesciences (NYSE: EW) 5% HIGHER; reported Q2 EPS of $0.34, $0.17 better than the analyst estimate of $0.17. Revenue for the quarter came in at $925 million versus the consensus estimate of $797.53 million. Edwards Lifesciences sees FY2020 EPS of $1.75-$1.95, versus the consensus of $1.63. Edwards Lifesciences sees FY2020 revenue of $4-4.5 billion, versus the consensus of $4.23 billion.

Skyworks Solutions (NASDAQ: SWKS) 2.4% LOWER; reported Q3 EPS of $1.25, $0.13 better than the analyst estimate of $1.12. Revenue for the quarter came in at $736.8 million versus the consensus estimate of $690.67 million. Skyworks Solutions sees Q4 2020 EPS of $1.51, versus the consensus of $1.47. Skyworks Solutions sees Q4 2020 revenue of $830-850 million, versus the consensus of $809.5 million.

Moderna, Inc. (NASDAQ: MRNA) 1.9% LOWER; adds to intra-day losses of 9.5% after losing a patent battle to Arbutus.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Tesla, Earnings, Pre-Open Losers, Pre-Open Winners, Pre Market Movers